Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dexamethasone 250micrograms/5ml oral liquid
0603020G0AABTBT
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | No data available |
|
Dexamethasone 3mg/5ml oral liquid
0603020G0AABWBW
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | No data available |
|
Dexamethasone 400microgram capsules
0603020G0AACECE
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | No data available |
|
Dexamethasone 4mg/1ml solution for injection ampoules
0603020H0AAABAB
|
Dexamethasone sodium phosphate (Parenteral) | Dexamethasone sodium phosphate | Endocrine System | No data available |
|
Dexamethasone 4mg/5ml oral liquid
0603020G0AAA8A8
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | No data available |
|
Dexamethasone 6mg/5ml oral liquid
0603020G0AABNBN
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | No data available |
|
Dexamethasone 8mg/2ml solution for injection vials
0603020H0AAAKAK
|
Dexamethasone sodium phosphate (Parenteral) | Dexamethasone sodium phosphate | Endocrine System | No data available |
|
Dexamethasone 8mg/5ml oral liquid
0603020G0AAA9A9
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | No data available |
|
Dexamfetamine 100mg/5ml oral liquid
0404000L0AAAQAQ
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 10mg modified-release capsules
0404000L0AABABA
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 10mg/5ml oral liquid
0404000L0AAANAN
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 125mg/5ml oral liquid
0404000L0AAAPAP
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 15mg modified-release capsules
0404000L0AAABAB
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 2.5mg/5ml oral liquid
0404000L0AAATAT
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 20mg/5ml oral solution
0404000L0AABJBJ
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 3mg/5ml oral liquid
0404000L0AAAUAU
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 45mg/5ml oral liquid
0404000L0AABBBB
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 5mg modified-release capsules
0404000L0AABCBC
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 7.5mg/5ml oral liquid
0404000L0AAARAR
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine powder
190400000AAJNJN
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Dexbrompheniramine 6mg/Pseudoephedrine sulfate 120mg MR tab
0310000M0AAADAD
|
Pseudoephedrine sulfate (combinations) | Pseudoephedrine sulfate combinations | Respiratory System | No data available |
|
Dexedrine 10mg Spansules
0404000L0BBAEBA
|
Dexedrine | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexedrine 15mg Spansules
0404000L0BBADAB
|
Dexedrine | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexedrine 5mg Spansules
0404000L0BBAFBC
|
Dexedrine | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexedrine 5mg tablets
0404000L0BBAAAJ
|
Dexedrine | Dexamfetamine sulfate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.